NOX4 stimulates ANF secretion via activation of the Sirt1/Nrf2/ATF3/4 axis in hypoxic beating rat atria

被引:1
|
作者
Li, Zhi-Yu [1 ,2 ]
Liu, Ying [1 ]
Wang, Yue-Ying [1 ]
Li, Xiang [1 ]
Han, Zhuo-Na [1 ]
Hong, Lan [1 ]
Li, Ying-Shun [1 ]
Cui, Xun [1 ,3 ]
机构
[1] Yanbian Univ, Sch Med Sci, Dept Physiol, 977 Gongyuan Rd, Yanji 133002, Jilin, Peoples R China
[2] Yanbian Univ, Med Off, Affiliated Hosp, Yanji 133000, Jilin, Peoples R China
[3] Yanbian Univ, Cellular Funct Res Ctr, Yanji 133000, Jilin, Peoples R China
基金
中国国家自然科学基金;
关键词
silent information regulator 1; nuclear factor erythroid-2-related factor 2; activating transcription factor; NADPH oxidase 4; atrial natriuretic factor; OXIDATIVE STRESS; SIRT1; HEART; APOPTOSIS; PATHWAYS; INJURY;
D O I
10.3892/mmr.2022.12600
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Silent information regulator factor 2-related enzyme 1 (Sirt1) is involved in the regulation of cell senescence, gene transcription, energy balance and oxidative stress. However, the effect of Sirt1 on atrial natriuretic factor (ANF) secretion, especially under hypoxic conditions is unclear. The present study aimed to investigate the effect of Sirt1, regulated by NADPH oxidase 4 (NOX4), on ANF secretion in isolated beating rat atria during hypoxia. ANF secretion was analyzed using radioimmunoassays and protein expression levels were determined by western blotting and immunofluorescence staining. Intra-atrial pressure was recorded using a physiograph. Hypoxia significantly upregulated Sirt1 and nuclear factor erythroid-2-related factor 2 (Nrf2) protein expression levels, together with significantly increased ANF secretion. Hypoxia-induced protein expression of Sirt1 was significantly blocked by a NOX4 inhibitor, GLX351322, and Nrf2 protein expression levels were significantly abolished using the Sirt1 inhibitor, EX527. Hypoxia also significantly elevated the protein expression levels of phosphorylated-Akt and sequestosome 1 and significantly downregulated Kelch-like ECH-associated protein 1 protein expression levels. These effects were significantly blocked by EX527, preventing hypoxia-induced Nrf2 expression. An Nrf2 inhibitor, ML385, significantly abolished the hypoxia-induced upregulation of activating transcription factor (ATF)3, ATF4, T cell factor (TCF)3 and TCF4/lymphoid enhancer factor 1 (LEF1) protein expression levels, and significantly attenuated hypoxia-induced ANF secretion. These results indicated that Sirt1 and Nrf2, regulated by NOX4, can potentially stimulate TCF3 and TCF4/LEF1 signaling via ATF3 and ATF4 activation, thereby potentially participating in the regulation of ANF secretion in beating rat atria during hypoxia. In conclusion, intervening with the Sirt1/Nrf2/ATF signaling pathway may be an effective strategy for resisting oxidative stress damage in the heart during hypoxia.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Cholecystokinin regulates atrial natriuretic peptide secretion through activation of NOX4-Sirt1-LEF1 signaling in beating rat hypoxic atria
    Xu, Li-jia
    Zhi, Meng-tao
    Lin, Xiao-xue
    Li, Xiang
    Li, Zhi-yu
    Cui, Xun
    PEPTIDES, 2024, 181
  • [2] NOX4/Src regulates ANP secretion through activating ERK1/2 and Akt/GATA4 signaling in beating rat hypoxic atria
    Wu, Cheng-Zhe
    Li, Xiang
    Hong, Lan
    Han, Zhuo-Na
    Liu, Ying
    Wei, Cheng-Xi
    Cui, Xun
    KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2021, 25 (02): : 159 - 166
  • [3] The Protective Role of Tanshinone IIA in Silicosis Rat Model via TGF-β1/Smad Signaling Suppression, NOX4 Inhibition and Nrf2/ARE Signaling Activation
    Feng, Feifei
    Cheng, Peng
    Zhang, Huanan
    Li, Nannan
    Qi, Yuxin
    Wang, Hui
    Wang, Yongbin
    Wang, Wei
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 4275 - 4290
  • [4] NOX4 blockade suppresses titanium nanoparticle-induced bone destruction via activation of the Nrf2 signaling pathway
    Wang, Wei
    Liang, Xiaolong
    Liu, Xin
    Bai, Jiaxiang
    Zhang, Wei
    Li, Wenming
    Wang, Tianhao
    Li, Meng
    Wu, Zerui
    Chen, Liang
    Yang, Huilin
    Gu, Ye
    Tao, Yunxia
    Zhou, Jun
    Wang, Huaiyu
    Geng, Dechun
    JOURNAL OF NANOBIOTECHNOLOGY, 2022, 20 (01)
  • [5] NOX4 blockade suppresses titanium nanoparticle-induced bone destruction via activation of the Nrf2 signaling pathway
    Wei Wang
    Xiaolong Liang
    Xin Liu
    Jiaxiang Bai
    Wei Zhang
    Wenming Li
    Tianhao Wang
    Meng Li
    Zerui Wu
    Liang Chen
    Huilin Yang
    Ye Gu
    Yunxia Tao
    Jun Zhou
    Huaiyu Wang
    Dechun Geng
    Journal of Nanobiotechnology, 20
  • [6] Cholecystokinin Octapeptide Promotes ANP Secretion through Activation of NOX4-PGC-1α-PPARα/PPARγ Signaling in Isolated Beating Rat Atria
    Han, Zhuo-na
    Lin, Xiao-xue
    Wang, Yue-ying
    Ding, Ran
    Hong, Lan
    Cui, Xun
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2022, 2022
  • [7] Nrf2 Activation Induced by Sirt1 Ameliorates Acute Lung Injury After Intestinal Ischemia/Reperfusion Through NOX4-Mediated Gene Regulation
    Chai, DongDong
    Zhang, Lei
    Xi, SiWei
    Cheng, YanYong
    Jiang, Hong
    Hu, Rong
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 46 (02) : 781 - 792
  • [8] Fucoidan alleviates hepatic lipid deposition by modulating the Perk-Eif2α-Atf4 axis via Sirt1 activation in Acanthopagrus schlegelii
    Zhao, Wenli
    Shen, Yuedong
    Bao, Yangguang
    Monroig, Oscar
    Zhu, Tingting
    Sun, Peng
    Tocher, Douglas R.
    Zhou, Qicun
    Jin, Min
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 282
  • [9] Nrf2 Inhibits Apoptosis and Suppresses Oxidative Stress By Activating NOX4/ERK1/2/ELK1 Signaling Axis in Human Chondrocytes
    Khan, Mohammad N.
    Ahmad, Imran
    Ansari, Mohammad Y.
    Haqqi, Tariq M.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [10] Meloxicam Targets COX-2/NOX1/NOX4/Nrf2 Axis to Ameliorate the Depression-like Neuropathology Induced by Chronic Restraint Stress in Rats
    Arab, Hany H.
    Khames, Ali
    Mohammad, Mostafa K.
    Alsufyani, Shuruq E.
    Ashour, Ahmed M.
    El-Sheikh, Azza A. K.
    Darwish, Hany W.
    Gad, Amany M.
    PHARMACEUTICALS, 2023, 16 (06)